Who Is and Is Not a Candidate
This is the most important part of the conversation, and it is why finasteride for women should always involve a thorough consultation rather than a quick prescription.
Women who cannot take finasteride include anyone who is pregnant, trying to become pregnant, or not using reliable contraception. Finasteride can cause serious birth defects in male fetuses, and even skin contact with broken or crushed tablets carries a risk. This is a firm contraindication, not a preference. Premenopausal women who are prescribed finasteride off-label must be using reliable birth control and must be counseled clearly on this risk.
Women who may be appropriate candidates include postmenopausal women with female pattern hair loss, premenopausal women who are not and do not intend to become pregnant and who are using reliable contraception, and women who have not responded adequately to first-line treatments like minoxidil.
Even for appropriate candidates, finasteride is not the right choice for everyone. Hormonal context matters, the underlying cause of the hair loss matters, and whether other factors like thyroid function or iron levels have been addressed first matters. This is why we do not prescribe it in isolation at NHLMA.
What Are the Alternatives?
Whether finasteride is right for you or not, there are several other treatments with strong evidence for female pattern hair loss worth knowing about.
-
Topical minoxidilis the most established FDA-approved treatment for women with pattern hair loss. It works differently from finasteride, stimulating follicle activity rather than addressing DHT, and it is appropriate for a much broader range of patients including premenopausal women.
-
Low-level laser therapy (LLLT)uses specific wavelengths of light to stimulate follicle metabolism and is a well-tolerated, non-hormonal option that works well as part of a combined protocol.
-
PRP (platelet-rich plasma)and exosome therapy both work by delivering concentrated growth signals directly to the scalp, supporting follicle health and encouraging the transition from resting to active growth phases. These are particularly effective when hair loss is in the earlier stages.
-
Nutritional and hormonal optimization through comprehensive labs is often the missing piece. Addressing iron deficiency, thyroid dysfunction, or hormonal imbalances that are driving the hair loss in the first place can make everything else work better and sometimes resolves shedding on its own.
-
Spironolactone is another off-label option for premenopausal women with androgen-driven hair loss, often considered before finasteride given its longer track record of use in women.
What We Actually See in Practice
At NHLMA, finasteride is one tool among many, and whether it belongs in a patient’s plan depends on a thorough evaluation first. We look at the type and pattern of hair loss, hormonal and nutritional labs, medical history, and reproductive considerations before discussing it as an option.
For postmenopausal women with confirmed androgenetic alopecia who have not responded to first-line treatments, it can be genuinely effective. For younger women, we typically explore other options first and have a detailed conversation about the risks before considering it.
What we do not do is treat female hair loss the way male hair loss is treated with a simple prescription and no deeper investigation. The two are fundamentally different problems that require different approaches.
